Viome’s Oral Health Pro System Detects Early Signs of Disease and Oral & Throat Cancer

Viome Life Sciences has released a new at-home testing kit that is available for both patients and dental professionals called Oral Health Pro™. This test uses a patient’s saliva to measure gene expressions and cells that are present there, then analyzing results for a variety of aspects, including markers for oral diseases as well as oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC). Per Viome, cancer-free specificity sits at greater than or equal to 95%, OSCC sensitivity is greater than or equal to 90%, with OPSCC sensitivity also greater than or equal to 90%.

After patients are done with their saliva test, they can then send their sample to Viome’s lab where results will be measured. Viome uses a proprietary RNA sequencing technology and artificial intelligence to measure markers and molecular features associated with OSCC and OPSCC, per a press release from Viome. Along with the standard results, Viome also provides a personalized treatment plan, allowing for further collaboration between the doctor and the patient. Through Oral Health Pro’s Oral Health Scores, clinicians can see where patients may need improvement or assistance.